Single award · contract

Clinical Development of CRISPR-CAS3 Phage Cocktail for the Treatment of Recurrent Urinary Tract Infections…

Award ID: 75A50120C00169

FY2020 · complete year · data as of 2026-07-12

A single federal award, with both ends of the trail linked.

$73.9M
Total award value

Award 75A50120C00169 is a contract from the Department of Health and Human Services, $73.9M obligated, FY2020 to FY2027, for Clinical Development of CRISPR-CAS3 Phage Cocktail for the Treatment of Recurrent Urinary Tract…. The work is performed in North Carolina. It is classified as NAICS 541714 (Research and Development in Biotechnology (except Nanobiotechnology)) and PSC AN13 (Health R&D Services; Health Care Services; Experimental Development). Source

Description

Clinical Development of CRISPR-CAS3 Phage Cocktail for the Treatment of Recurrent Urinary Tract Infections Caused by Escherichia Coli Including Antimicrobial and Multi-Drug Resistant Strains

Award details

Award typeContract
PIID75A50120C00169
Action date2020
Period75 mo
RecipientOutside our Phase 1 contractor set: see methodology
Place of performanceNorth Carolina →
Competed?Not recordedSource
Total (exact)$73,885,104

More from Department of Health and Human Services

Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.